Characterization of a new potent, in vivo neutralizing monoclonal antibody to human vascular endothelial growth factor

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 6, 1999, Pages 336-342

  Schlaeppi, Jean Marc ^a   Siemeister, Gerhard ^b,c   Weindel, Karin ^b   Schnell, Christian ^a   Wood, Jeanette ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b TUMOR BIOLOGY CENTER   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

Angiogenesis; Epitope; Neutralizing antibody; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPITOPE; GROWTH FACTOR; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VASCULOTROPIN;

ANTIGEN BINDING; ARTICLE; DOSE RESPONSE; DRUG POTENCY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMAN; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; EPITOPE MAPPING; HUMANS; LYMPHOKINES; MICE; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033054581     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050283     Document Type: Article

References (36)

1. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt 4). Proc Natl Acad Sci USA 95:548-553
2. 121. Cancer Res 55:5296-5301
3. Asano M, Yukita A, Matsumoto T, Hanatani M, Suzuki H (1998) An anti-human VEGF monoclonal antibody. MV833, that exhibits potent anti-tumor activity in vivo. Hybridoma 17:185-190
4. Borgström P, Hillan KJ, Srimararao P, Ferrara N (1996) Complete inhibition of angiogenesis and growth of microtumors by antivascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 56:4032-4039
5. Cheng S-Y, Su Huang H-J, Nagane M, Ji X-D, Wang D, Shih CC-Y, Arap W, Huang CM, Cavenee WK (1996) Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci USA 93:8502-8507
6. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991
7. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039
8. Eppenberger U, Kueng W, Schlaeppi J-M, Roesel JL, Benz C, Mueller H, Matter A, Zuber M, Luescher K, Litschgi M, Schmitt M, Foekens JA, Eppenberger-Castori S (1998) Markers of tumor angiogenesis and proteolysis (VEGF, uPA) independently define high-and low-risk subsets of node-negative breast cancer patients. J Clin Oncol 16:3129-3136
9. Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocrine Rev 18:4-25
10. Ferrara N, Houck K, Jakeman L, Leung DW (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Rev 13:18-32
11. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442
12. Fiebich BL, Jäger B, Schöllmann C, Weindel K, Wilting J, Kochs G, Marmé D, Hug H, Weich HA (1993) Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells. Eur J Biochem 211:19-26
13. Folkman J (1992) The role of angiogenesis in tumor growth. Semin Cancer Biol 3:66-71
14. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease, Nature Med 1:27-31
15. Folkman J, Shing Y (1992) Angiogenesis, J Biol Chem 267:10931-10934
16. Karlsson R, Fält A (1997) Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. J Immunol Methods 200:121-133
17. Keyt BA, Nguyen HV, Berleau LT, Duarte CM, Park J, Chen H, Ferrara N (1996) Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem 271:5638-5646
18. Kim KJ, Li B, Houck K, Winer J, Ferrara N (1992) The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 7:53-64
19. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841-844
20. Linderholm B, Tavelin B, Grankvist K, Henriksson R (1998) Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J Clin Oncol 16:3121-3128
21. Maeda K, Chung Y-S, Ogawa Y, Takatsuka S, Kang S-M, Ogawa M, Sawada T, Sowa M (1996) Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77:858-863
22. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267-9271
23. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367:576-578
24. Muller YA, Li B, Christinger HW, Wells JA, Cunningham BC, De Vos AM (1997a) Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proc Natl Acad Sci USA 94:7192-7197
25. Muller YA, Christinger HW, Keyt BA, De Vos AM (1997b) The crystal structure of vascular endothelial growth factor (VEFG) to 1.93 Å resolution: multiple copy flexibility and receptor binding. Structure 5:1325-1338
26. Paley PJ, Staskus KA, Gebhard K, Mohanraj D, Twiggs LB, Carson LF, Ramakrishnan S (1997) Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 80:98-106
27. Saleh M, Stacker SA, Wilks AF (1996) Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56:393-401
28. Schlaeppi J-M, Eppenberger U, Martiny-Baron G, Küng W (1996) Chemiluminescence immunoassay for vascular endothelial growth factor (vascular permeability factor) in tumor-tissue homogenates. Clin Chem 42:1777-1784
29. Siemeister G, Schirner M, Reusch P, Barleon B, Marmé D, Martiny-Baron G (1998a) An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells. Proc Natl Acad Sci USA 95:4625-4629
30. Siemeister G, Marmé D, Martiny-Baron G (1998b) The alpha-helical domain near the amino-terminus is essential for dimerization of vascular endothelial growth factor. J Biol Chem 273:11115-11120
31. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187:1579-1586
32. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947-11954
33. Toi M, Inada K, Suzuki H, Tominaga T (1995) Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36:193-204
34. Volm M, Koomägi R, Mattern J (1997) Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer 74:64-68
35. Weidner N (1993) Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagnost Path 10:302-313
36. Wiesmann C, Fuh G, Christinger HW, Eigenbrot C, Wells JA, De Vos AM (1997) Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91:695-704